|
|
|
| home > white papers > Maximize the ROI of Your Post-Approval Research - Bioclinica |
|
|
 WHITE PAPERS |
|
|
Bioclinica
|
|
Maximize the ROI of Your Post-Approval Research
|
|
Expenditures in post-approval (Phase IV) research are going up across
the pharmaceutical, biotech and medical device industries. Given the
resources you’ve committed to post-approval research, you may be
wondering if you’re getting the greatest possible return on your
investment.
Discover how to harness the power of post-approval
research to increase data collection, reduce resource burn, save money,
and maximize your ROI!
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Stevanato Group signs an agreement with Nelson Labs to provide best-in-class Extractables and Leachables testing services at its US Technology Excellence Center
Piombino Dese, Padua Italy and Salt Lake City, USA September 2, 2020:
Italian-based Stevanato Group, a leading producer of glass primary
packaging and provider of integrated services for combination products,
and Nelson Laboratories, LLC, a global provider of lab testing and
expert advisory services signed today a partnership agreement that will
provide Extractables and Leachables testing at SG US Technology
Excellence Center in Boston, MA.
More info >> |
|
 |
White Papers |
 |
|
7 Common Myths about QP Training Debunked: A Guide for Senior Managers
RSSL
The role of the Qualified Person (QP) in the pharmaceutical industry is mandated by law (Directive 2001/83/EC, Directive 2001/20/EC, UK SI 2012/1916, UK SI 2004/103). Every holder of a relevant Manufacturers Authorisation (human and veterinary) must have at least one QP; without one, no batch of medicinal product can be certified for release for sale.
More info >> |
|
 |
Industry Events |
 |
Bio Integrates 2021
20 May 2021, VIRTUAL CONFERENCE
Following the continued success of last year’s inaugural digital event,
Life Science Integrates is delighted to announce the 3rd Bio Integrates
conference. Addressing the needs of innovative companies developing the
therapies of tomorrow, this one-day conference provides a unique forum
to discuss the major challenges impacting the sector.
More info >> |
|
|
|
